Please use this identifier to cite or link to this item: https://doi.org/10.1002/pbc.20684
Title: Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
Authors: Kwok, C.S.
Kham, S.K.
Quah, T.C. 
Yeoh, A.E. 
Ariffin, H.
Lin, H.P.
Keywords: ALL
Drug efficacy
L-asparaginase
Leukemia
Minimal residual disease
Issue Date: 2006
Citation: Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P. (2006). Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer 47 (3) : 299-304. ScholarBank@NUS Repository. https://doi.org/10.1002/pbc.20684
Source Title: Pediatric Blood and Cancer
URI: http://scholarbank.nus.edu.sg/handle/10635/25684
ISSN: 15455009
15455017
DOI: 10.1002/pbc.20684
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.